Aeluma, Inc.
Latest List Rankings
Current Synopsis
Aeluma is the venture-style photonics name in the 5x list. The verified appeal is early commercial pull: more than $4M of recent quantum-dot laser/materials contracts, six development engagements totaling $5M, and enough cash to keep pushing commercialization. The stock belongs here because a tiny market cap can move violently on proof of scale, not because the business is already proven.
Current Pillar Scores
5x model: market-cap asymmetry is 88.0/100 at roughly $395.0M current market cap, which is why size matters more here than business quality alone.
The earnings/growth score is driven by reported fundamentals, not narrative. revenue growth -2.6%, gross margin 37.7%, operating margin -173.9%, profit margin -115.5%, FCF margin -8.5%. Component support: explosive growth 35.2, survival 80.9.
ALMU's catalyst is optionality in photonics and advanced optical integration. The argument is compelling only if framed correctly: this is not a proven AI infrastructure supplier today. It is a small public venture bet on technologies that could become more valuable as AI systems push optical interconnect and sensing requirements higher.
July technical setup is 43/100 from refreshed price history: 20-day return -22.8%, 60-day return 74.7%, 120-day return 5.9%, distance from 52-week high -35.5%. Above 50dma: false; above 200dma: true.
For July this pillar is better read as options/positioning confirmation, not social-media fluff. ATM implied volatility 143.5%, call/put OI 2.2, call/put volume 3.5, OTM call OI share 44.9%, short % float 23.8%, short ratio 1.5. Component support: options/squeeze 85.5.
The base Goldilox math is roughly $395M today versus a $1.0B bull case, or about 2.53x. The 5x label reflects stretch-case optionality from a tiny base, not a high-confidence base-case forecast. The page should make that distinction explicit because ALMU is riskier than the probability number alone implies.
Current Path to Target
A 5x requires Aeluma to convert photonics R&D into real commercial demand, show that its technology belongs in AI/optical infrastructure supply chains, and raise capital without destroying the upside. This is a low-probability, high-convexity setup.
The July 2x path requires more than a normal rerating: Aeluma is the venture-style photonics name in the 5x list. The stock needs sustained evidence that the AI catalyst is translating into durable revenue and margin expansion, while the refreshed July market cap still leaves room for a credible doubling if execution stays clean.
Current Key Risk
This is the riskiest top-three 5x name. Revenue is still mostly R&D-contract scale, commercial visibility is limited, and the stock can fail even if the technology is interesting. Position sizing should reflect venture-like downside.
Current Key Metrics
BRRR Appearance History
Current analysis stays canonical. This is the compact scoreboard of where the name has shown up across monthly BRRR lists.
Subscribe for monthly updates on this stock and the full rankings
Keep the latest thesis current, while the appearance history shows how conviction evolved over time.
Subscribe Free →